A Non-interventional Prospective Study of 1-st Line Treatment Approaches in OVArian Cancer Patients With HRD+ Status in Russian Federation
Clinical trial NCT05918042 · COMPLETED
Trial details
- NCT number
- NCT05918042
- Sponsor
- AstraZeneca
- Status
- COMPLETED
- Study type
- OBSERVATIONAL
- Start date
- 2023-06-21
- Primary completion
- 2025-05-29
- Enrollment
- 414
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.